Skip to main content
Erschienen in: Acta Neuropathologica 5/2013

01.05.2013 | Review

The role of mast cells in neuroinflammation

verfasst von: Sofie Nelissen, Evi Lemmens, Nathalie Geurts, Peter Kramer, Marcus Maurer, Jerome Hendriks, Sven Hendrix

Erschienen in: Acta Neuropathologica | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Mast cells (MCs) are densely granulated perivascular resident cells of hematopoietic origin and well known for their pathogenetic role in allergic and anaphylactic reactions. In addition, they are also involved in processes of innate and adaptive immunity. MCs can be activated in response to a wide range of stimuli, resulting in the release of not only pro-inflammatory, but also anti-inflammatory mediators. The patterns of secreted mediators depend upon the given stimuli and microenvironmental conditions, accordingly MCs have the ability to promote or attenuate inflammatory processes. Their presence in the central nervous system (CNS) has been recognized for more than a century. Since then a participation of MCs in various pathological processes in the CNS has been well documented. They can aggravate CNS damage in models of brain ischemia and hemorrhage, namely through increased blood–brain barrier damage, brain edema and hemorrhage formation and promotion of inflammatory responses to such events. In contrast, recent evidence suggests that MCs may have a protective role following traumatic brain injury by degrading pro-inflammatory cytokines via specific proteases. In neuroinflammatory diseases such as multiple sclerosis, the role of MCs seems to be ambiguous. MCs have been shown to be damaging, neuroprotective, or even dispensable, depending on the experimental protocols used. The role of MCs in the formation and progression of CNS tumors such as gliomas is complex and both positive and negative relationships between MC activity and tumor progression have been reported. In summary, MCs and their secreted mediators modulate inflammatory processes in multiple CNS pathologies and can thereby either contribute to neurological damage or confer neuroprotection. This review intends to give a concise overview of the regulatory roles of MCs in brain disease.
Literatur
1.
Zurück zum Zitat Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H, Tenen DG, Austen KF, Akashi K (2005) Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 102(50):18105–18110. doi:10.1073/pnas.0509148102 PubMedCrossRef Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H, Tenen DG, Austen KF, Akashi K (2005) Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 102(50):18105–18110. doi:10.​1073/​pnas.​0509148102 PubMedCrossRef
2.
Zurück zum Zitat Bennett JL, Blanchet MR, Zhao L, Zbytnuik L, Antignano F, Gold M, Kubes P, McNagny KM (2009) Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol 182(9):5507–5514. doi:10.4049/jimmunol.0801485 PubMedCrossRef Bennett JL, Blanchet MR, Zhao L, Zbytnuik L, Antignano F, Gold M, Kubes P, McNagny KM (2009) Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol 182(9):5507–5514. doi:10.​4049/​jimmunol.​0801485 PubMedCrossRef
5.
Zurück zum Zitat Carlson T, Kroenke M, Rao P, Lane TE, Segal B (2008) The Th17-ELR + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 205(4):811–823. doi:10.1084/jem.20072404 PubMedCrossRef Carlson T, Kroenke M, Rao P, Lane TE, Segal B (2008) The Th17-ELR + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 205(4):811–823. doi:10.​1084/​jem.​20072404 PubMedCrossRef
6.
Zurück zum Zitat Christy AL, Brown MA (2007) The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J Immunol 179(5):2673–2679 (pii:179/5/2673)PubMed Christy AL, Brown MA (2007) The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J Immunol 179(5):2673–2679 (pii:179/5/2673)PubMed
7.
Zurück zum Zitat Costa JJ, Weller PF, Galli SJ (1997) The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278(22):1815–1822PubMedCrossRef Costa JJ, Weller PF, Galli SJ (1997) The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278(22):1815–1822PubMedCrossRef
8.
Zurück zum Zitat Couturier N, Zappulla JP, Lauwers-Cances V, Uro-Coste E, Delisle MB, Clanet M, Montagne L, Van der Valk P, Bo L, Liblau RS (2008) Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol 195(1–2):176–185. doi:10.1016/j.jneuroim.2008.01.017 PubMedCrossRef Couturier N, Zappulla JP, Lauwers-Cances V, Uro-Coste E, Delisle MB, Clanet M, Montagne L, Van der Valk P, Bo L, Liblau RS (2008) Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol 195(1–2):176–185. doi:10.​1016/​j.​jneuroim.​2008.​01.​017 PubMedCrossRef
10.
Zurück zum Zitat Dropp JJ (1979) Mast cells in the human brain. Acta Anat (Basel) 105(4):505–513CrossRef Dropp JJ (1979) Mast cells in the human brain. Acta Anat (Basel) 105(4):505–513CrossRef
11.
Zurück zum Zitat Du T, Friend DS, Austen KF, Katz HR (1996) Tissue-dependent differences in the asynchronous appearance of mast cells in normal mice and in congenic mast cell-deficient mice after infusion of normal bone marrow cells. Clin Exp Immunol 103(2):316–321PubMedCrossRef Du T, Friend DS, Austen KF, Katz HR (1996) Tissue-dependent differences in the asynchronous appearance of mast cells in normal mice and in congenic mast cell-deficient mice after infusion of normal bone marrow cells. Clin Exp Immunol 103(2):316–321PubMedCrossRef
12.
13.
Zurück zum Zitat Ehrlich P (1879) Über die spezifischen Granulationen des Blutes. Arch Anat Physiol Abteil 571–579 Ehrlich P (1879) Über die spezifischen Granulationen des Blutes. Arch Anat Physiol Abteil 571–579
15.
Zurück zum Zitat Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, Radermacher P, Moller P, Benoist C, Mathis D, Fehling HJ, Rodewald HR (2011) Cre-mediated cell ablation contests mast cell contribution in models of antibody- and t cell-mediated autoimmunity. Immunity 35(5):832–844. doi:10.1016/j.immuni.2011.09.015 PubMedCrossRef Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, Radermacher P, Moller P, Benoist C, Mathis D, Fehling HJ, Rodewald HR (2011) Cre-mediated cell ablation contests mast cell contribution in models of antibody- and t cell-mediated autoimmunity. Immunity 35(5):832–844. doi:10.​1016/​j.​immuni.​2011.​09.​015 PubMedCrossRef
18.
Zurück zum Zitat Galli SJ, Hammel I (1994) Mast cell and basophil development. Curr Opin Hematol 1(1):33–39PubMed Galli SJ, Hammel I (1994) Mast cell and basophil development. Curr Opin Hematol 1(1):33–39PubMed
20.
Zurück zum Zitat Galli SJ, Kitamura Y (1987) Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 127(1):191–198PubMed Galli SJ, Kitamura Y (1987) Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 127(1):191–198PubMed
23.
Zurück zum Zitat Gilfillan AM, Beaven MA (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31(6):475–529 (pii:20591c2466aedc19,222bcdb718a38c7c)PubMedCrossRef Gilfillan AM, Beaven MA (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31(6):475–529 (pii:20591c2466aedc19,222bcdb718a38c7c)PubMedCrossRef
25.
Zurück zum Zitat Gordon JR, Galli SJ (1994) Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 180(6):2027–2037PubMedCrossRef Gordon JR, Galli SJ (1994) Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 180(6):2027–2037PubMedCrossRef
26.
Zurück zum Zitat Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167(3):835–848PubMedCrossRef Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167(3):835–848PubMedCrossRef
27.
Zurück zum Zitat Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8(10):1095–1104. doi:10.1038/ni1503 PubMedCrossRef Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8(10):1095–1104. doi:10.​1038/​ni1503 PubMedCrossRef
30.
Zurück zum Zitat Hendrix S, Kramer P, Pehl D, Warnke K, Boato F, Nelissen S, Lemmens E, Pejler G, Metz M, Siebenhaar F, Maurer M (2012) Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J. doi:10.1096/fj.12-204800 PubMed Hendrix S, Kramer P, Pehl D, Warnke K, Boato F, Nelissen S, Lemmens E, Pejler G, Metz M, Siebenhaar F, Maurer M (2012) Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J. doi:10.​1096/​fj.​12-204800 PubMed
32.
Zurück zum Zitat Hendrix S, Warnke K, Siebenhaar F, Peters EM, Nitsch R, Maurer M (2006) The majority of brain mast cells in B10.PL mice is present in the hippocampal formation. Neurosci Lett 392(3):174–177PubMedCrossRef Hendrix S, Warnke K, Siebenhaar F, Peters EM, Nitsch R, Maurer M (2006) The majority of brain mast cells in B10.PL mice is present in the hippocampal formation. Neurosci Lett 392(3):174–177PubMedCrossRef
33.
Zurück zum Zitat Henz BM, Maurer M, Lippert U, Worm M, Babina M (2001) Mast cells as initiators of immunity and host defense. Exp Dermatol 10(1):1–10PubMedCrossRef Henz BM, Maurer M, Lippert U, Worm M, Babina M (2001) Mast cells as initiators of immunity and host defense. Exp Dermatol 10(1):1–10PubMedCrossRef
34.
Zurück zum Zitat Hough LB (1988) Cellular localization and possible functions for brain histamine: recent progress. Prog Neurobiol 30(6):469–505 (pii:0301-0082(88)90032-9)PubMedCrossRef Hough LB (1988) Cellular localization and possible functions for brain histamine: recent progress. Prog Neurobiol 30(6):469–505 (pii:0301-0082(88)90032-9)PubMedCrossRef
35.
Zurück zum Zitat Ibrahim MZ, Reder AT, Lawand R, Takash W, Sallouh-Khatib S (1996) The mast cells of the multiple sclerosis brain. J Neuroimmunol 70(2):131–138 (pii:0165-5728(96)00102-6)PubMedCrossRef Ibrahim MZ, Reder AT, Lawand R, Takash W, Sallouh-Khatib S (1996) The mast cells of the multiple sclerosis brain. J Neuroimmunol 70(2):131–138 (pii:0165-5728(96)00102-6)PubMedCrossRef
36.
38.
Zurück zum Zitat Johnson D, Krenger W (1992) Interactions of mast cells with the nervous system—recent advances. Neurochem Res 17(9):939–951PubMedCrossRef Johnson D, Krenger W (1992) Interactions of mast cells with the nervous system—recent advances. Neurochem Res 17(9):939–951PubMedCrossRef
39.
Zurück zum Zitat Karasuyama H, Mukai K, Tsujimura Y, Obata K (2009) Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev 9(1):9–13. doi:10.1038/nri2458 Karasuyama H, Mukai K, Tsujimura Y, Obata K (2009) Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev 9(1):9–13. doi:10.​1038/​nri2458
40.
Zurück zum Zitat Kendall JC, Li XH, Galli SJ, Gordon JR (1997) Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99(1 Pt 1):113–123 (pii:S0091674997000055)PubMed Kendall JC, Li XH, Galli SJ, Gordon JR (1997) Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99(1 Pt 1):113–123 (pii:S0091674997000055)PubMed
41.
Zurück zum Zitat Korkmaz OT, Tuncel N, Tuncel M, Oncu EM, Sahinturk V, Celik M (2010) Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells. J Mol Neurosci 41(2):278–287. doi:10.1007/s12031-009-9307-3 PubMedCrossRef Korkmaz OT, Tuncel N, Tuncel M, Oncu EM, Sahinturk V, Celik M (2010) Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells. J Mol Neurosci 41(2):278–287. doi:10.​1007/​s12031-009-9307-3 PubMedCrossRef
43.
Zurück zum Zitat Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21(1):1–23, vii Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21(1):1–23, vii
44.
Zurück zum Zitat Li H, Nourbakhsh B, Safavi F, Li K, Xu H, Cullimore M, Zhou F, Zhang G, Rostami A (2011) Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol 187(1):274–282. doi:10.4049/jimmunol.1003603 PubMedCrossRef Li H, Nourbakhsh B, Safavi F, Li K, Xu H, Cullimore M, Zhou F, Zhang G, Rostami A (2011) Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol 187(1):274–282. doi:10.​4049/​jimmunol.​1003603 PubMedCrossRef
45.
Zurück zum Zitat Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML (2010) Mast cells as early responders in the regulation of acute blood–brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 30(4):689–702. doi:10.1038/jcbfm.2009.282 PubMedCrossRef Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML (2010) Mast cells as early responders in the regulation of acute blood–brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 30(4):689–702. doi:10.​1038/​jcbfm.​2009.​282 PubMedCrossRef
46.
Zurück zum Zitat Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8(5):500–508. doi:10.1038/nm0502-500 PubMedCrossRef Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8(5):500–508. doi:10.​1038/​nm0502-500 PubMedCrossRef
50.
Zurück zum Zitat Manni L, Micera A, Pistillo L, Aloe L (1998) Neonatal handling in EAE-susceptible rats alters NGF levels and mast cell distribution in the brain. Int J Dev Neurosci 16(1):1–8 (pii:S0736-5748(98)00003-3)PubMedCrossRef Manni L, Micera A, Pistillo L, Aloe L (1998) Neonatal handling in EAE-susceptible rats alters NGF levels and mast cell distribution in the brain. Int J Dev Neurosci 16(1):1–8 (pii:S0736-5748(98)00003-3)PubMedCrossRef
51.
Zurück zum Zitat Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev 4(10):787–799CrossRef Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev 4(10):787–799CrossRef
52.
Zurück zum Zitat Maslinska D, Laure-Kamionowska M, Maslinski KT, Gujski M, Maslinski S (2007) Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm Res 56(Suppl 1):S17–S18PubMedCrossRef Maslinska D, Laure-Kamionowska M, Maslinski KT, Gujski M, Maslinski S (2007) Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm Res 56(Suppl 1):S17–S18PubMedCrossRef
53.
Zurück zum Zitat Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ (2004) Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432(7016):512–516. doi:10.1038/nature03085 PubMedCrossRef Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ (2004) Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432(7016):512–516. doi:10.​1038/​nature03085 PubMedCrossRef
54.
Zurück zum Zitat McCurdy JD, Lin TJ, Marshall JS (2001) Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70(6):977–984PubMed McCurdy JD, Lin TJ, Marshall JS (2001) Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70(6):977–984PubMed
55.
Zurück zum Zitat McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK (2003) Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 100(13):7761–7766. doi:10.1073/pnas.1231488100 PubMedCrossRef McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK (2003) Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 100(13):7761–7766. doi:10.​1073/​pnas.​1231488100 PubMedCrossRef
56.
Zurück zum Zitat Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77(4):1033–1079PubMed Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77(4):1033–1079PubMed
59.
Zurück zum Zitat Miller HR, Pemberton AD (2002) Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105(4):375–390 (pii:1375)PubMedCrossRef Miller HR, Pemberton AD (2002) Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105(4):375–390 (pii:1375)PubMedCrossRef
63.
Zurück zum Zitat Neumann J (1890) Ueber das Vorkommen der sogenannten „Mastzellen” bei pathologischen Veränderungen des Gehirns. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 122(2) Neumann J (1890) Ueber das Vorkommen der sogenannten „Mastzellen” bei pathologischen Veränderungen des Gehirns. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 122(2)
64.
Zurück zum Zitat Niederhoffer N, Levy R, Sick E, Andre P, Coupin G, Lombard Y, Gies JP (2009) Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses. Int J Immunopathol Pharmacol 22(2):473–483PubMed Niederhoffer N, Levy R, Sick E, Andre P, Coupin G, Lombard Y, Gies JP (2009) Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses. Int J Immunopathol Pharmacol 22(2):473–483PubMed
65.
Zurück zum Zitat Schmidt OI, Infanger M, Hyde CE, Ertel W, Stahel PF (2004) The role of neuroinflammation in traumatic brain injury. Eur J Trauma 30:135–149CrossRef Schmidt OI, Infanger M, Hyde CE, Ertel W, Stahel PF (2004) The role of neuroinflammation in traumatic brain injury. Eur J Trauma 30:135–149CrossRef
66.
Zurück zum Zitat Olsson Y (1974) Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 50(5):611–618PubMedCrossRef Olsson Y (1974) Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 50(5):611–618PubMedCrossRef
67.
Zurück zum Zitat Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC (1996) Definitive characterization of rat hypothalamic mast cells. Neuroscience 73(3):889–902 (pii:0306-4522(95)00606-0)PubMedCrossRef Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC (1996) Definitive characterization of rat hypothalamic mast cells. Neuroscience 73(3):889–902 (pii:0306-4522(95)00606-0)PubMedCrossRef
68.
Zurück zum Zitat Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1998) Neuronal histamine deficit in Alzheimer’s disease. Neuroscience 82(4):993–997 (pii:S0306452297003539)PubMedCrossRef Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1998) Neuronal histamine deficit in Alzheimer’s disease. Neuroscience 82(4):993–997 (pii:S0306452297003539)PubMedCrossRef
69.
Zurück zum Zitat Piconese S, Costanza M, Musio S, Tripodo C, Poliani PL, Gri G, Burocchi A, Pittoni P, Gorzanelli A, Colombo MP, Pedotti R (2011) Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. Lab Invest 91(4):627–641. doi:10.1038/labinvest.2011.3 PubMedCrossRef Piconese S, Costanza M, Musio S, Tripodo C, Poliani PL, Gri G, Burocchi A, Pittoni P, Gorzanelli A, Colombo MP, Pedotti R (2011) Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. Lab Invest 91(4):627–641. doi:10.​1038/​labinvest.​2011.​3 PubMedCrossRef
70.
Zurück zum Zitat Polajeva J, Sjosten AM, Lager N, Kastemar M, Waern I, Alafuzoff I, Smits A, Westermark B, Pejler G, Uhrbom L, Tchougounova E (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS ONE 6(9):e25222. doi:10.1371/journal.pone.0025222 PubMedCrossRef Polajeva J, Sjosten AM, Lager N, Kastemar M, Waern I, Alafuzoff I, Smits A, Westermark B, Pejler G, Uhrbom L, Tchougounova E (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS ONE 6(9):e25222. doi:10.​1371/​journal.​pone.​0025222 PubMedCrossRef
72.
Zurück zum Zitat Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390(6656):172–175. doi:10.1038/36586 PubMedCrossRef Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390(6656):172–175. doi:10.​1038/​36586 PubMedCrossRef
75.
Zurück zum Zitat Robbie-Ryan M, Tanzola MB, Secor VH, Brown MA (2003) Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 170(4):1630–1634PubMed Robbie-Ryan M, Tanzola MB, Secor VH, Brown MA (2003) Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 170(4):1630–1634PubMed
76.
Zurück zum Zitat Rodewald HR, Dessing M, Dvorak AM, Galli SJ (1996) Identification of a committed precursor for the mast cell lineage. Science 271(5250):818–822PubMedCrossRef Rodewald HR, Dessing M, Dvorak AM, Galli SJ (1996) Identification of a committed precursor for the mast cell lineage. Science 271(5250):818–822PubMedCrossRef
78.
Zurück zum Zitat Sayed BA, Christy AL, Walker ME, Brown MA (2010) Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 184(12):6891–6900. doi:10.4049/jimmunol.1000126 PubMedCrossRef Sayed BA, Christy AL, Walker ME, Brown MA (2010) Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 184(12):6891–6900. doi:10.​4049/​jimmunol.​1000126 PubMedCrossRef
80.
Zurück zum Zitat Secor VH, Secor WE, Gutekunst CA, Brown MA (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191(5):813–822PubMedCrossRef Secor VH, Secor WE, Gutekunst CA, Brown MA (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191(5):813–822PubMedCrossRef
81.
Zurück zum Zitat Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R (1998) Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol 90(2):207–211 (pii:S0165572898001374)PubMedCrossRef Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R (1998) Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol 90(2):207–211 (pii:S0165572898001374)PubMedCrossRef
82.
Zurück zum Zitat Sharma N, Kumar V, Everingham S, Mali RS, Kapur R, Zeng LF, Zhang ZY, Feng GS, Hartmann K, Roers A, Craig AW (2012) SH2 domain-containing phosphatase-2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice. Mol Cell Biol. doi:10.1128/MCB.00308-12 Sharma N, Kumar V, Everingham S, Mali RS, Kapur R, Zeng LF, Zhang ZY, Feng GS, Hartmann K, Roers A, Craig AW (2012) SH2 domain-containing phosphatase-2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice. Mol Cell Biol. doi:10.​1128/​MCB.​00308-12
84.
Zurück zum Zitat Silver R, Silverman AJ, Vitkovic L, Lederhendler II (1996) Mast cells in the brain: evidence and functional significance. Trends Neurosci 19(1):25–31 (pii:0166223696818637)PubMedCrossRef Silver R, Silverman AJ, Vitkovic L, Lederhendler II (1996) Mast cells in the brain: evidence and functional significance. Trends Neurosci 19(1):25–31 (pii:0166223696818637)PubMedCrossRef
85.
Zurück zum Zitat Silverman AJ, Sutherland AK, Wilhelm M, Silver R (2000) Mast cells migrate from blood to brain. J Neurosci 20(1):401–408PubMed Silverman AJ, Sutherland AK, Wilhelm M, Silver R (2000) Mast cells migrate from blood to brain. J Neurosci 20(1):401–408PubMed
86.
Zurück zum Zitat Skaper SD, Facci L, Romanello S, Leon A (1996) Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 66(3):1157–1166PubMedCrossRef Skaper SD, Facci L, Romanello S, Leon A (1996) Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 66(3):1157–1166PubMedCrossRef
87.
Zurück zum Zitat Stelekati E, Bahri R, D’Orlando O, Orinska Z, Mittrucker HW, Langenhaun R, Glatzel M, Bollinger A, Paus R, Bulfone-Paus S (2009) Mast cell-mediated antigen presentation regulates CD8 + T cell effector functions. Immunity 31(4):665–676. doi:1016/j.immuni.2009.08.022 PubMedCrossRef Stelekati E, Bahri R, D’Orlando O, Orinska Z, Mittrucker HW, Langenhaun R, Glatzel M, Bollinger A, Paus R, Bulfone-Paus S (2009) Mast cell-mediated antigen presentation regulates CD8 + T cell effector functions. Immunity 31(4):665–676. doi:1016/​j.​immuni.​2009.​08.​022 PubMedCrossRef
88.
90.
Zurück zum Zitat Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ (2007) Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116(4):411–418. doi:10.1161/CIRCULATIONAHA.106.655423 PubMedCrossRef Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ (2007) Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116(4):411–418. doi:10.​1161/​CIRCULATIONAHA.​106.​655423 PubMedCrossRef
91.
93.
Zurück zum Zitat Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ (2007) Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 27(4):795–802. doi:10.1038/sj.jcbfm.9600387 PubMed Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ (2007) Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 27(4):795–802. doi:10.​1038/​sj.​jcbfm.​9600387 PubMed
96.
Zurück zum Zitat Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171(8):4385–4391PubMed Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171(8):4385–4391PubMed
97.
103.
Zurück zum Zitat Tuncel N, Sener E, Cerit C, Karasu U, Gurer F, Sahinturk V, Baycu C, Ak D, Filiz Z (2005) Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson’s disease model in rats: brain microdialysis, behavior, and microscopy. Peptides 26(5):827–836. doi:10.1016/j.peptides.2004.12.019 PubMedCrossRef Tuncel N, Sener E, Cerit C, Karasu U, Gurer F, Sahinturk V, Baycu C, Ak D, Filiz Z (2005) Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson’s disease model in rats: brain microdialysis, behavior, and microscopy. Peptides 26(5):827–836. doi:10.​1016/​j.​peptides.​2004.​12.​019 PubMedCrossRef
105.
Zurück zum Zitat Welle M (1997) Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 61(3):233–245PubMed Welle M (1997) Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 61(3):233–245PubMed
106.
Zurück zum Zitat Zappulla JP, Arock M, Mars LT, Liblau RS (2002) Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol 131(1–2):5–20PubMedCrossRef Zappulla JP, Arock M, Mars LT, Liblau RS (2002) Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol 131(1–2):5–20PubMedCrossRef
Metadaten
Titel
The role of mast cells in neuroinflammation
verfasst von
Sofie Nelissen
Evi Lemmens
Nathalie Geurts
Peter Kramer
Marcus Maurer
Jerome Hendriks
Sven Hendrix
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 5/2013
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-013-1092-y

Weitere Artikel der Ausgabe 5/2013

Acta Neuropathologica 5/2013 Zur Ausgabe

Thanks to referees

Thanks to referees

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.